A whole-body MRI has been mostly a boutique experience. Fitnescity Health, which calls itself the largest US network of ...
TimeWarp Longevity Protocol combines 25 compounds, a monthly senolytic reset and an app – one system built around the 2025 ...
Formerly Kesmalea, the London company says its degraders cross the blood-brain barrier in pieces, then self-assemble on the ...
New data covers the Wegovy pill in real life, an investigational drug at lower doses, and children as young as six.
GSK and Alamar will profile more than 60,000 serum samples to see how one diagnosis can hide several diseases.
Eisai’s CTAD slate includes five-year Clarity AD data, a real-world symposium and a look at lecanemab and donanemab dosing.
From brain scans to Super Mario, NeuroAge and TruDiagnostic explain how Younger turns personal health goals into public ...
Built with David Sinclair for Grok Bot, the free multi-agent system turns personal health data into checkable N-of-1 experiments.
Mission Therapeutics has begun a 36-patient Phase 1b study of MTX325, a drug aimed at clearing out damaged mitochondria in ...
A late-breaking slot in Boston will bring fresh data on an experimental drug that aims to turn down tau production in the ...
SIR2501, a SARM1 blocker with FDA Fast Track status for chemo nerve damage, gets three poster slots in Washington.
Ultrahuman’s racing partnership is about more than lap times; the bigger story is the teenage years when female healthspan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results